These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 916668)

  • 21. Short-term effects of norethisterone oenanthate and medroxyprogesterone acetate on glucose, insulin, growth hormone, and lipids.
    Dhall K; Kumar M; Rastogi GK; Devi PK
    Fertil Steril; 1977 Feb; 28(2):156-8. PubMed ID: 832727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of norethisterone acetate on ovarian functional activity].
    Fanchenko ND; Anashkina GA; Kuzovkova NA; Adamian LV; Strizhakov AN
    Probl Endokrinol (Mosk); 1982; 28(2):38-42. PubMed ID: 7079254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of norethindrone in women. II. Single-dose kinetics.
    Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Rowe PH; Smith E
    Clin Pharmacol Ther; 1978 Oct; 24(4):448-53. PubMed ID: 688734
    [No Abstract]   [Full Text] [Related]  

  • 24. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
    Sarkar NN; Laumas V; Agarwal N; Hingorani V; Laumas KR
    Acta Obstet Gynecol Scand; 1983; 62(1):71-6. PubMed ID: 6858629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
    Bergink W; Assendorp R; Kloosterboer L; van Lier W; Voortman G; Qvist I
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2132-7. PubMed ID: 2147817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels of norethisterone in women with subcutaneous implants of norethisterone acetate.
    Joshi JV; Naik VK; Joshi UM
    Indian J Med Res; 1979 Oct; 70():625-31. PubMed ID: 541006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of norethindrone in women. I. Radioimmunoassay and concentrations during multiple dosing.
    Back DJ; Breckenridge AM; Crawford FE; Mciver M; Orme ML; Park BK; Rowe PH; Smith E
    Clin Pharmacol Ther; 1978 Oct; 24(4):439-47. PubMed ID: 567550
    [No Abstract]   [Full Text] [Related]  

  • 29. Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate.
    Laumas V; Malik BK; Jamal K; Seth U; Agarwal N; Hingorani V; Laumas KR
    Contraception; 1978 Dec; 18(6):593-605. PubMed ID: 750187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norethisterone oenanthate as an injectable contraceptive.
    Gray RH
    Br Med J; 1979 Feb; 1(6159):343. PubMed ID: 421110
    [No Abstract]   [Full Text] [Related]  

  • 31. Radioimmunoassay system for norethisterone using 3H- and 125I-labelled radioligands.
    Morris SE; Cameron EH
    J Steroid Biochem; 1975 Jul; 6(7):1145-50. PubMed ID: 1177442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of norethindrone after i.m. injection of 200 mg norethindrone enanthate.
    Weiner E; Johansson ED
    Contraception; 1975 Apr; 11(4):419-25. PubMed ID: 1122756
    [No Abstract]   [Full Text] [Related]  

  • 33. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive.
    Beck LR; Pope VZ; Flowers CE; Cowsar DR; Tice TR; Lewis DH; Dunn RL; Moore AB; Gilley RM
    Biol Reprod; 1983 Feb; 28(1):186-95. PubMed ID: 6830939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with norethisterone enanthate as injectable contraceptive.
    Khan AR; Mosley WH; Jahan FA
    Bangladesh Med Res Counc Bull; 1976 Dec; 2(2):131-8. PubMed ID: 1037371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
    Beksinska ME; Rees HV
    Afr J Reprod Health; 2001 Dec; 5(3):84-8. PubMed ID: 12471932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Radioimmunoassays for plasma norethisterone and testosterone using antisera raised against C-11 conjugated haptens and radio-iodinated ligands.
    Hillier SG; Read GF
    J Endocrinol; 1975 Nov; 67(2):5P-6P. PubMed ID: 1206298
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of intramuscular norethisterone enanthate on compensatory ovarian hypertrophy in the rat.
    Srivastava UK
    Indian J Physiol Pharmacol; 1981; 25(2):151-7. PubMed ID: 7287136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting contraceptive agents: the influence of physico-chemical properties of some esters of norethisterone upon the plasma levels of free norethisterone.
    Enever RP; Fotherby K; Naderi S; Lewis GA
    Steroids; 1983 Mar; 41(3):381-96. PubMed ID: 6658883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.